Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IIR-17011926Phase 4Recruiting
Phase 4, randomised, open-label trial of total glucosides of paeony in autoimmune hepatitis (AIH) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Complete remission rate. Started Jul 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IIR-17011926.